Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

J. Horning, Sandra; Younes, Anas; Jain, Vinay; Kroll, Stewart; B. Lucas, Jennifer; A. Podoloff, Donald; L. Goris, Michael

doi:10.1200/jco.2005.07.040

Public

Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

Published in Journal of Clinical Oncology • Dec 22, 2004

Authors:

Sandra J. Horning

Anas Younes

Vinay Jain

Abstract

PURPOSE: To determine overall response (OR) and complete response (CR) rates, response duration, progression-free (PFS) and overall survival and safety with the tositumomab and iodine-131 tositumomab ((131)I tositumomab) therapeutic regimen in patients with indolent, follicular large-cell, or transf...

Subject

Medicine

Rituximab

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!